Delivery Order SPE2DB24D2100-SPE2DB24FBCWC
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of CIMZIA 2X200 MG/ML syringe kits. The contract, valued at $6,602.82, is a firm-fixed-price delivery order without a set-aside designation. The award has an ultimate completion date of July 19, 2024. AmerisourceBergen, through its Corporate Office division, will provide these critical medical supplies to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,708,436 units of the medication CIMZIA (certolizumab pegol) 2x200 mg/mL syringe kits. The award, valued at $5,874.88, is a firm fixed-price delivery order with a completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,861.39, is a delivery order for CIMZIA 2X200 MG/ML syringe kits. The contract has an ultimate completion date of January 6, 2025 and is a firm fixed-price arrangement. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This federal contract award, valued at $5,793.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, a specialty medication used for various medical conditions. The contract has an ultimate completion date of March 26, 2025 and is structured as a firm fixed-price delivery order. The award is not associated with a set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,115.18 firm fixed-price delivery order is for the supply of CIMZIA 2X200 MG/ML syringe kits, with a period of performance through April 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CIMZIA 2X200 MG/ML syringe kits. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,640.41 and a performance period running through July 16, 2025. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $6,560.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, a specialty medication. It is a Firm Fixed Price Delivery Order with a completion date of June 4, 2024. The award is not associated with a set-aside program, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $16,505.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIMZIA 2X200 MG/ML SYRINGE KITS, which are specialty pharmaceutical products. The contract has a firm fixed price pricing type and an ultimate completion date of May 21, 2024. The contract is a delivery order, and there is no set-aside designation indicated....
- This federal contract award, valued at $14,122.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CIMZIA 2X200 MG/ML syringe kits, which are pharmaceutical products. The contract is a delivery order with a firm fixed-price pricing type and has an ultimate completion date of July 2, 2025. It is not designated as a set-aside contract, indicating open...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of 4,566,736,858 units of CIMZIA 2X200 MG/ML syringe kits, a specialty pharmaceutical product, at a ceiling value of $15,262.94. The contract is a firm fixed-price arrangement with no set-aside designation, indicating...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB24FBCWCDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,565,378,570 units of the pharmaceutical product CIMZIA 2X200 MG/ML SYRINGE KITS. The award, valued at $6,560.58, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 8, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to supply the critical medication to support military treatment facilities and other federal healthcare providers nationwide. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to the U.S. government. The contract did not utilize a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 8/7/24 |